"Designing Growth Strategies is in our DNA"

Urticaria Treatment Market Size, Share & Industry Analysis, By Disease Type (Acute Urticaria, Chronic Urticaria), By Drug Type (Antihistamines, H2-blockers, Monoclonal Antibodies, Antidepressants, Other), By Route Of Administration (Oral, Topical, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and Regional Forecast 2021-2028

Region : Global | Report ID: FBI103495 | Status : Ongoing

 

KEY MARKET INSIGHTS

Urticaria, also known as hives, occurs when the body reacts to an allergen and relaeses histamine and other chemicals from under the surface of the skin. The histamine and chemicals cause inflammation and fluid to accumulate under the skin, causing wheals. Urticaria can be treated using drugs such as antihistamines, H2-blockers, monoclonal antibodies, antidepressants. Factors such as rising cases of urticaria, growing awareness regarding hypersensitivity and allergies, and growing drug approvals for urticaria treatment are some of the major factors that are contributing in accelerating the growth of the global market during the forecast period. For instance, In October 2019, JDP Therapeutics received USFDA approval for cetirizine injection (quzyttir) for acute urticaria.


The urticaria treatment market is expected to register a significant growth during the forecast period due to factors such rising prevalence of urticaria, rise in drug approvals for the treatment, and growing awareness regarding the allergic reactions. However, preference for other treatment options such as homeopathy is the major factor expected to limit the growth of urticaria treatment market.


Key Market Driver -

Rising prevalence of urticaria, rise in drug approvals for the treatment

Key Market Restraint -

Preference for other treatment options such as homeopathy


Market Segmentation:


Globally, the urticaria treatment market can be segmented on the basis of the disease type, drug type, route of administration, distribution channel and region. Based on the disease type, the market can be segmented into acute urticaria and chronic urticaria. Based on drug type, the market can be segmented into antihistamines, H2-blockers, monoclonal antibodies, antidepressants, and others. Based on the route of administration, the market can be segmented into oral, topical, and parenteral. Based on distribution channel, the market can be segmented into hospital pharmacies, retail pharmacies, and others. Geographically, the urticaria treatment market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.


Key Players Covered:


Some of the major companies that are present in the urticaria treatment market are Pfizer Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson Services Inc., Sanofi, Genentech, Inc., Teva Pharmaceutical Industries Ltd., and other prominent players.


Key Insights:



  • Prevalence of Urticaria, By Country/Region

  • Key Industry Trends

  • New Product Launches

  • Key Industry Developments Mergers, Acquisitions, And Collaborations


Regional Analysis:


Geographically, the urticaria treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to lead the global urticaria treatment market. Increasing incidence of urticaria, well developed healthcare facilities, and significant research investments are the major factors attributable to the expansion of market in North America. For instance, according to Allergy & Asthma Network, chronic spontaneous urticaria (CSU) affects approximately 1.6 million people in U.S. High awareness of the disease and people focusing on improving the quality of life are the factors anticipated to foster the market in Europe. On the other hand, Asia Pacific is expected to register the highest CAGR owing to the rising prevalence of urticaria and increasing healthcare expenditure in the region. The market in Latin America and the Middle East & Africa are in limited stage of growth. However, significant developments for the improvement of the healthcare sector is likely to help witness a significant growth in the market in the forthcoming years.


To gain extensive insights into the market, Request for Customization


Segmentation






























 ATTRIBUTE


 DETAILS

By Disease Type




  • Acute Urticaria

  • Chronic Urticaria



By Drug Type




  • Antihistamines

  • H2-blockers

  • Monoclonal Antibodies

  • Antidepressants

  • Others



By Route Of Administration




  • Oral

  • Topical

  • Parenteral



By Distribution Channel




  • Hospital Pharmacies

  • Retail Pharmacies

  • Others



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)



Urticaria Treatment Market Industry Developments



  • In October 2019, JDP Therapeutics received USFDA approval for cetirizine injection (quzyttir ) for acute urticaria.

  • In September 2018, Novartis AG announced the USFDA approval for Xolair (omalizumab) prefilled syringe formulation for chronic idiopathic urticaria.


Urticaria Treatment Market  Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • $4850
    $6850
    $8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Fresenius
3M
Siemens Healthineers
Ansell
Pfizer

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X